NEW YORK, NY, Mobile app that provides on-demand access to the best prices on last-minute theater tickets, today announced a $9 million Series B round. Read More
PALO ALTO, CA, Clinical-stage immuno-oncology company, announced today that it has completed the first half of a committed $75 million Series A financing round. Read More